BiomeSense is pioneering the field of gut microbiome analysis with the first clinically-validated, fully-automated, continuous monitoring system. Their innovative technology enables frequent, low-burden sampling, providing unprecedented visibility into gut microbiome dynamics. This empowers researchers to accelerate discovery, enables clinicians to practice precision medicine, and allows individuals to proactively manage their health.
The headquarters serves as the primary center for research and development, device engineering, software creation, clinical trial operations, and corporate administration.
Located within Portal Innovations, BiomeSense has access to state-of-the-art shared laboratory spaces, advanced R&D equipment, and collaborative office environments specifically designed for life science startups. The Fulton Market district offers a dynamic and modern setting.
The work culture is characterized as fast-paced, innovative, and highly collaborative, driven by a strong mission to advance gut health. It emphasizes scientific excellence, interdisciplinary teamwork (integrating hardware, software, and biology), and translating cutting-edge research into practical health solutions.
BiomeSense's headquarters is crucial as the central hub for developing its novel microbiome monitoring technology, conducting clinical validations, and strategizing market entry. Its location within a biotech incubator like Portal Innovations provides vital resources, networking opportunities, and a supportive ecosystem for growth.
BiomeSense's core operations, including research, development, and initial clinical studies, are currently centered in the United States. Their technology has global implications for microbiome research and personalized medicine, and they actively engage in international research collaborations with plans for future global market expansion.
1375 West Fulton St.
Chicago
IL
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, BiomeSense' leadership includes:
BiomeSense has been backed by several prominent investors over the years, including:
No significant public announcements regarding executive new hires or exits at BiomeSense have been identified in the last 12 months. The current leadership team appears stable, particularly following their Series A funding round in early 2023.
Discover the tools BiomeSense uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
BiomeSense likely utilizes common professional email formats for its employees. While not publicly confirmed, a typical structure for companies of its size and in the biotech sector would be based on employee names, often using a first name and last name combination.
[first].[last]@biomesense.com
Format
kevin.honaker@biomesense.com
Example
90%
Success rate
GlobeNewswire • January 17, 2024
BiomeSense, Inc. and Microba Life Sciences (ASX: MAP) have partnered to combine BiomeSense's continuous microbiome monitoring technology with Microba's metagenomic analysis platform to enhance gut health diagnostics and therapeutic development....more
PR Newswire • May 2, 2023
BiomeSense secured $15M in Series A funding co-led by Duke University and MOBAP, with participation from existing and new investors. The funds will be used to scale manufacturing of its novel biosensor technology, expand clinical validation studies, and further develop its continuous gut microbiome monitoring system....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including BiomeSense, are just a search away.